IMV - IMV shareholders to effect 1-for-10 reverse stock split

• Biopharmaceutical company IMV ( NASDAQ: IMV ) ( TSX: IMV:CA ) to effect a 1-for-10 reverse stock split, having said its shareholders have approved the consolidation plan with 87.87% votes.
• The board approved a 1-for-10 reverse stock split of the company's shares immediately after the shareholder meeting.
• The reverse stock split is set to become effective on Dec. 7, 5:00 p.m. ET.
• The shares are expected to commence trading on a split-adjusted basis from Dec. 13, market open, under the current trading symbol, IMV.
• The new CUSIP number for the shares post the reverse stock split will be 44974L301.
• The reverse stock split aims to bring the company in compliance with Nasdaq's minimum required closing bid price.
• The company said its warrants will be impacted by the reverse stock split ratio upon exercise.
• IMV's current issued and outstanding shares are 82,369,960, and after the split the expected issued and outstanding shares will be 8,236,996 shares.
• Source: Press Release

For further details see: